1st
Pharmacy Practice During and Beyond Times of Crisis

2nd

Heart Failure: Evolving Therapies and Novel Indications

3rd

Pharmacy Education and Board Certification:

Driving Practice Change

4th

Parental Nutrition PN

Clinical & Practical Considerations

5th

Biosimilars Summit

Therapeutic Utility and Globalization Challenges

6th

Pharmacy Automation and Informatics: Innovating Patient Care

7th

Pharmacy Evolution: Professional Generations in Action

8th

Management of Migraine:

Winning the Battle Against a Chronic Disease

9th

The role of Pharmacists in Empowering Asthma Patients

10th
New Trends in Cancer Care
 

11th

Clinical Scenarios in parenteral and enteral nutrition

12th
Brand vs Generic Putting the Patient First
 

13th
Individualized Approach in Diabetes Management

14th

Critical Care Controversies Pharmacotherapy Insights

15th
Current Best Practices and Future Directions: Multiple Sclerosis 2021

16th
Dry Eye Disease: Scoping the role of Pharmacists

17th
Chronic Lymphocytic Leukemia CLL - Value of Innovation in Cancer Treatments

18th
Scoping Medication Management Technologies

19th
The Role of Pharmacist in the Management of Type-2 Asthma

20th
Dyslipidemia: Navigating Horizons from Prevention to Treatment

21st
Pain Management: What the Pharmacist Should Know?

22nd
Prostate Ca: Value of Innovation in Cancer Treatment

23rd
Hyperkalemia Management: Innovative Treatments for an Old Disease

24th
The Art and Science of Medications’ Patient Counselling

25th
Clinical Research: New Perspectives and Insights

26th
Parenteral Nutrition Role in The Hospitalized Patients: An Overview

27th
Multiple Myeloma: Value of Innovation in Cancer Treatments

29th
Parenteral Nutrition Updates

30th
The Pharmacoeconomics of Multiple Sclerosis

31st
The IV Lipid Revolution:
From Theory to Practice

32nd
Reforming Mental Health
for a Better Wellbeing

33rd
The Art and Science of Ready-to-Use TPN Bags

34th
IVPN Technology:
Closing the Loop in Automation

36th
Parenteral Nutrition Role in Pediatrics and Neonates

37th
Challenges with Current Growth Hormone Treatment

38th
Omega 3 Fatty Acids in Dyslipidemia:
Connecting Evidence with Practice

39th
Atopic Dermatitis Beyond A Skin Disease

40th
Improving the Tolerance to Peripheral Parenteral Nutrition

41st
AML Pharmacotherapy:
Current and Future Horizons

42th
Evolving Role of Immunotherapy in Lung Cancer

43rd
Protein and Lipid in Pediatrics and Neonates: Experience from The Bedside

44th
Pain Management:
A Patient-Centered Approach

45th
Economical Burden in Breast Cancer

46th
Triple Chamber PN Bags in Adults:
Practical and Clinical Considerations

47th
Multiple Myeloma:
Therapeutic Options and Future Horizons

48th
Triple Chamber PN Bags in Neonates:
Practical & Clinical Considerations

49th
The Role of Health Technology Assessment for Biosimilars

50th
CLL Management in Saudi Arabia: Is this the time to give your patient an upgrade?

51st
Preventing PN Complications Experience from The Bedside

52nd
Severe Asthma: Clinical Pearls on Management and Prevention

53rd
Chronic Lymphocytic Leukemia: Therapeutic Considerations and Economic Burden

54th
2nd Gulf Oncology Health Economics Summit
 

55th
aTTP Stronger Start Makes A Difference
 

56th
Monoclonal Antibodies for COVID-19 Vulnerable Patients

57th
Dyslipidemia: Redefining Our Goals
 

58th
Rare Disease Educational Series Part 1:
Focus on Paroxysmal Nocturnal Hemoglobinuria

59th
Dyslipidemia Management:
where are we and where are we going?

60th
Prostate Cancer Disease:
Burden and Early Treatment Options

61st
Economic Burden in Oncology (Part 2)
Sickle Cell Disease

62nd
Stemline Blastic Plasma Chroid Neoplasm
 

63rd
Alopecia Areata Management:
Current Landscape and Emerging Therapies

64th
Medication Adherence in Dyslipidemia Pharmacotherapy The: Optimization Journey

65th
New Era of Migraine Management: Role of Rimegepant

66th
BREAST CANCER : Therapeutic Options and Future Horizons

67th
Dyslipidemia: Optimizing Outcomes Beyond Pharmacotherapy

68th
Lupus Management Updates
 

69th
Updates on Managing Growth Disorders: Game Changer Therapies

70th
Chronic Lymphocytic Leukemia Management:
The Holistic Approach

71st
Economic Burden in Oncology Part #3
Chronic Myeloid Leukemia

72nd
Multiple Myeloma:
A Glimpse into The Future Therapeutics

Youth IVPN-AR
Biostatistics and Research:
Translating data into action

74th
Prescribing Skills for Pharmacists The Current Challenges and Future Directions